Pluri Inc (PLUR.TA)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 427,000 185,000 326,000 96,000
Cost of Revenue 291,000 74,000 126,000 65,000
Gross Profit 136,000 111,000 200,000 31,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,493,000 2,143,000 2,509,000 2,731,000
Operating Expenses 5,728,000 5,068,000 5,901,000 6,130,000
Operating Income -5,592,000 -4,957,000 -5,701,000 -6,034,000
Interest Expense -212,000 211,000 217,000 218,000
Income Before Tax -6,335,000 -3,110,000 -6,036,000 -5,862,000
Income Tax Expense 0 0 0 228,000
Net Income -6,335,000 -2,956,000 -5,882,000 -5,729,000
Per Share
EPS -0.94 -0.53 -1.12 -1.06
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue 1,336,000 326,000 287,000 234,000
Cost of Revenue 682,000 4,000 9,000 0
Gross Profit 654,000 322,000 278,000 234,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 9,979,000 10,034,000 11,779,000 17,450,000
Operating Expenses 23,983,000 22,480,000 27,524,000 41,827,000
Operating Income -23,329,000 -22,158,000 -27,246,000 -41,593,000
Interest Expense 873,000 866,000 843,000 887,000
Income Before Tax -23,250,000 -21,344,000 -28,887,000 -41,374,000
Income Tax Expense 0 0 277,000 755,000
Net Income -23,250,000 -20,888,000 -28,321,000 -41,242,000
Per Share
EPS -3.56 -3.99 -6.24 -1.28
EPS Diluted 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 5,895,000 6,783,000 5,360,000 9,772,000
Short Term Investments 0 23,202,000 34,811,000 45,244,000
Net Receivables 0 646,000 527,000 1,321,000
Inventory 0 0 0 0
Total Current Assets 22,095,000 31,107,000 41,409,000 57,747,000
Property Plant Equipment 8,723,000 7,246,000 8,321,000 9,009,000
Goodwill and Intangibles 5,929,000 0 0 0
Total Assets 16,588,000 39,527,000 50,797,000 68,065,000
Liabilities
Account Payables 1,329,000 964,000 1,812,000 1,785,000
Short Term Debt 659,000 1,118,000 627,000 619,000
Total Current Liabilities 32,328,000 4,454,000 5,621,000 6,829,000
Long Term Debt 6,102,000 29,053,000 29,278,000 28,183,000
Total Liabilities 7,220,000 34,112,000 35,497,000 35,879,000
Shareholders Equity
Retained Earnings -443,055,000 -420,472,000 -399,584,000 -371,263,000
Total Shareholders Equity -6,842,000 96,000 13,355,000 30,039,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 5,895,000 6,783,000 5,360,000 9,772,000
Short Term Investments 0 23,202,000 34,811,000 45,244,000
Net Receivables 0 646,000 527,000 1,321,000
Inventory 0 0 0 0
Total Current Assets 22,095,000 31,107,000 41,409,000 57,747,000
Property Plant Equipment 8,723,000 7,246,000 8,321,000 9,009,000
Goodwill and Intangibles 5,929,000 0 0 0
Total Assets 16,588,000 39,527,000 50,797,000 68,065,000
Liabilities
Account Payables 1,329,000 964,000 1,812,000 1,785,000
Short Term Debt 659,000 1,118,000 627,000 619,000
Total Current Liabilities 32,328,000 4,454,000 5,621,000 6,829,000
Long Term Debt 6,102,000 29,053,000 29,278,000 28,183,000
Total Liabilities 7,220,000 34,112,000 35,497,000 35,879,000
Shareholders Equity
Retained Earnings -443,055,000 -420,472,000 -399,584,000 -371,263,000
Total Shareholders Equity -6,842,000 96,000 13,355,000 30,039,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -23,250,000 -21,344,000 -28,887,000 -41,374,000
Depreciation & Amortization 316,000 253,000 362,000 1,053,000
Stock Based Compensation 2,143,000 2,618,000 3,977,000 8,909,000
Change in Working Capital 0 -21,000 1,691,000 -5,089,000
Operating Cash Flow -18,211,000 -18,021,000 -22,857,000 -36,501,000
Investing Activities
Capital Expenditure -1,618,000 -323,000 -262,000 -280,000
Investments -1,618,000 -323,000 -262,000 -280,000
Investing Cash Flow 8,026,000 10,584,000 9,698,000 11,783,000
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 0 91,000 8,024,000 0
Dividends Paid 0 0 0 0
Financing Cash Flow 9,533,000 8,841,000 8,024,000 7,500,000
Summary
Free Cash Flow -19,829,000 -18,344,000 -23,119,000 -36,781,000
Net Change in Cash -475,000 1,415,000 -5,157,000 -20,425,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -23,250,000 -21,344,000 -28,887,000 -41,374,000
Depreciation & Amortization 316,000 253,000 362,000 1,053,000
Stock Based Compensation 2,143,000 2,618,000 3,977,000 8,909,000
Change in Working Capital 0 -21,000 1,691,000 -5,089,000
Operating Cash Flow -18,211,000 -18,021,000 -22,857,000 -36,501,000
Investing Activities
Capital Expenditure -1,618,000 -323,000 -262,000 -280,000
Investments -1,618,000 -323,000 -262,000 -280,000
Investing Cash Flow 8,026,000 10,584,000 9,698,000 11,783,000
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 0 91,000 8,024,000 0
Dividends Paid 0 0 0 0
Financing Cash Flow 9,533,000 8,841,000 8,024,000 7,500,000
Summary
Free Cash Flow -19,829,000 -18,344,000 -23,119,000 -36,781,000
Net Change in Cash -475,000 1,415,000 -5,157,000 -20,425,000